The trading price of Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) closed higher on Friday, December 06, and closing at $1.65, 15.38% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $1.45 and $1.68. In examining the 52-week price action we see that the stock hit a 52-week high of $5.67 and a 52-week low of $0.60. Over the past month, the stock has gained 76.85% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Reviva Pharmaceuticals Holdings Inc, whose market valuation is $63.67 million at the time of this writing, is expected to release its quarterly earnings report in January. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.23 per share this quarter, however they have predicted annual earnings per share of -1.0 for current year and -0.84 for next year.
On the technical side, indicators suggest RVPH has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a Hold, while an average of long term indicators suggests that the stock is currently Hold.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned RVPH a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Reviva Pharmaceuticals Holdings Inc (RVPH) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that RVPH’s price is currently 35.74% off the SMA20 and 36.70% off the SMA50. The RSI metric on the 14-day chart is currently showing 70.83, and weekly volatility stands at 13.20%. When measured over the past 30 days, the indicator reaches 14.05%. Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s beta value is currently sitting at -0.03, while the Average True Range indicator is currently displaying 0.15.
To see how Reviva Pharmaceuticals Holdings Inc stock has been performing in comparison to its peers in the industry, here are the numbers: RVPH stock’s performance was 15.38% in the latest trading, and -55.16% in the past year.
An evaluation of the daily trading volume of Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) indicates that the 3-month average is 474.05K. However, this figure has increased over the past 10 days to an average of 0.72.
Currently, records show that 33.44 million of the company’s shares remain outstanding. The insiders hold 14.79% of outstanding shares, whereas institutions hold 30.47%. The stats also highlight that short interest as of 2024-10-31, stood at 5.3 million shares, resulting in a short ratio of 19.04 at that time. From this, we can conclude that short interest is 1859.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were down slightly from the previous month’s figure, which was 5.47 million. However, since the stock’s price has seen -67.96% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
